Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) was the target of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 15,700 shares, a decrease of 29.0% from the February 13th total of 22,100 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Basilea Pharmaceutica Price Performance
BPMUF stock opened at $52.83 on Friday. Basilea Pharmaceutica has a twelve month low of $38.60 and a twelve month high of $52.83. The business has a 50 day simple moving average of $52.83 and a 200-day simple moving average of $52.48. The company has a debt-to-equity ratio of 5.70, a current ratio of 4.10 and a quick ratio of 3.27.
About Basilea Pharmaceutica
Read More
- Five stocks we like better than Basilea Pharmaceutica
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- EV Stocks and How to Profit from Them
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are the U.K. Market Holidays? How to Invest and Trade
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.